Moderna's COVID-19 vaccine has been applied for approval
By Lee, Tak-Sun | translator Choi HeeYoung
21.04.12 17:03:00
°¡³ª´Ù¶ó
0
The MFDS announced on the 12th that GC Pharma has applied for approval as an import item for COVID-19 vaccine from Moderna in the US.
Moderna vaccine is one of the vaccines announced by the government and was developed in a two-doses (28 days apart). It is the same platform as Pfizer¡¯s Comirnaty, which is approved in Korea as a 'mRNA vaccine' that induces an immune response by injecting the antigenic gene of COVID-19 in the form of mRNA to generate antigenic protein in the body.
The government announced
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)